{"result_id": "086002", "URL": "https://www.cureus.com/articles/68051-toxic-epidermal-necrolysis-post-covid-19-vaccination---first-reported-case", "timestamp": "2023-04-25 14:52:55 CEST+0200", "meta": {"description": "Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a spectrum of acute, delayed-type hypersensitivity reactions that affect the skin and the mucous membranes. Medications are the culprit cause of these disorders in addition to infections and in very rare instances vaccinations. We report a case of TEN in a 49-year-old woman with no previous medical history. The disorder developed one week after receiving the first dose of COVID-19 vaccine with no other identifiable causes. The patient received two doses of tumor necrosis factor-alpha inhibitor (etanercept) and she stopped developing new lesions after two days of the initial dose; complete healing was observed after 22 days\u00a0and no side effects were observed in our patient. This case demonstrates an extremely rare complication to the COVID-19 vaccine. The benefits of receiving the COVID-19 outweigh the potential risk.", "lang": "en", "keywords": "", "favicon": "https://assets.cureus.com/packs/media/images/favicon-6b3259c58f4356da2cc885357cfda20b.png", "canonical": "https://www.cureus.com/articles/68051-toxic-epidermal-necrolysis-post-covid-19-vaccination---first-reported-case", "encoding": "utf-8"}, "image": null, "domain": "www.cureus.com", "title": "Toxic Epidermal Necrolysis Post COVID-19 Vaccination - First Reported Case", "cleaned_text": "On May 25, 2018, the GDPR (General Data Protection Regulation) went into effect and changed how organizations deal with personal data of customers located in the EU. Though GDPR was built to protect Europeans, it will affect organizations around the world doing business in the EU. Because of this we are asking our users located in the EU to opt in to the data we collect in order to bring a better web experience. Opt-In", "opengraph": {"title": "Toxic Epidermal Necrolysis Post COVID-19 Vaccination - First Reported Case", "type": "article", "image": "https://assets.cureus.com/uploads/figure/file/246340/article_river_9934b690fe8b11ebaf40fb1db1d6f21b-lightbox_a5c5eff0f3cd11ebaf87376b9e759ad8-p1fc470uvbduelq81k5s1ok21shk4-1.png", "description": "Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a spectrum of acute, delayed-type hypersensitivity reactions that affect the skin and the mucous membranes. Medications are the culprit cause of these disorders in addition to infections and in very rare instances vaccinations. We report a case of TEN in a 49-year-old woman with no previous medical history. The disorder developed one week after receiving the first dose of COVID-19 vaccine with no other identifiable causes. The patient received two doses of tumor necrosis factor-alpha inhibitor (etanercept) and she stopped developing new lesions after two days of the initial dose; complete healing was observed after 22 days\u00a0and no side effects were observed in our patient. This case demonstrates an extremely rare complication to the COVID-19 vaccine. The benefits of receiving the COVID-19 outweigh the potential risk.\u00a0"}, "tags": [], "tweets": [], "movies": [], "links": ["/users/gdpr_opt_in"], "authors": ["Areej  Almazroo", "Dr.Rifah R. Alturki", "Sulaiman  Obaid", "Hanan Almeshal", "Rifah  Alturki", "Mohamad Bakir "], "publish_date": null}